Morningstar Investor users sign in here.

Company Profile

  • Business description

    Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

  • Contact

    285 East Grand Avenue
    South San Francisco CA 94080
    USA

    T: +1 650 416-1192

    E: ir@unitybiotechnology.com

    https://www.unitybiotechnology.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    19

Stocks News & Analysis

stocks

Going into earnings, Is Apple stock a buy, a sell, or fairly valued?

Watching iPhone revenue, gross margins, and services growth.
stocks

One of the hottest shares on the ASX reports strong growth

Should investors chase this growth story or are they overvalued after the surge in the shares.  
stocks

Diverging value in Australia's real estate sector

One stock dominates Australia's A-REIT index and it has had an incredibly strong year. Our analysts see value elsewhere.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,153.40 59.10 0.73%
CAC 40 7,517.68 90.66 1.22%
DAX 40 18,417.55 118.83 0.65%
Dow JONES (US) 40,589.34 654.27 1.64%
FTSE 100 8,285.71 99.36 1.21%
HKSE 17,021.31 16.34 0.10%
NASDAQ 17,357.88 176.16 1.03%
Nikkei 225 37,667.41 202.10 -0.53%
NZX 50 Index 12,349.47 46.80 -0.38%
S&P 500 5,459.10 59.88 1.11%
S&P/ASX 200 7,921.30 60.10 0.76%
SSE Composite Index 2,890.90 4.16 0.14%

Market Movers

Name
Last price
Change
% Change
Bellevue Gold Ltd BGL 1.44 0.40 -21.58%
Argosy Minerals Ltd AGY 0.05 0.01 41.18%
Red 5 Ltd RED 0.38 0.02 -5.06%
Pilbara Minerals Ltd PLS 2.98 0.11 3.83%
Droneshield Ltd DRO 1.40 0.09 -6.04%
Sayona Mining Ltd SYA 0.03 0.00 0.00%
Core Lithium Ltd CXO 0.10 0.01 6.59%
Zip Co Ltd ZIP 1.78 0.04 -1.93%
South32 Ltd S32 2.98 0.07 2.41%
Telstra Group Ltd TLS 3.85 0.01 0.26%